Mylan Defers Product Launches Amid Generic Competition

Mylan said it was deferring all major product launches in the U.S. until next year amid disappointing sales and regulatory uncertainty, denting the drug maker’s earnings outlook.

from WSJ.com: US Business http://ift.tt/2vlWgye
via IFTTT